F2c.*C20209T mutation in patients with a history of thrombosis: A case report, retrospective 2 site‐results and review of the literature

Abstract

IntroductionG20210A (c.*97G>A) prothrombin gene variant, found in white population has been associated with an increased risk of venous thromboembolism (VTE). Other rare polymorphisms in F2 gene (C20209T) have been reported, more rare and touching black people, but its potential association with VTE remain uncertain.MethodsAbout a 69 years‐old Caucasian woman presenting an unprovoked deep venous thrombosis of the leg, we analyzed retrospectively 25.000 thrombophilia tests on a 11‐year period of time (2007–2018), at Nice and Marseille University Hospitals, and performed extensive review of the literature.ResultsGenetic determination included a similar PCR protocol and sequencing. Twenty‐one heterozygous cases out of 25.585 determinations (0.08%) was found. The C20209T mutation detected in our Caucasian patient is rare, with a frequency that differed from what was reported in the previous literature, mainly in non‐Caucasian patients (Africans, Africans‐Americans, and Caribbeans). One hundred and thirteen patients with this mutation have been described in the literature, of which only one homozygous.ConclusionThis study is the most important on C20209T mutation performed at present, allowing to precise its frequency and its potential role in venous thromboembolism.